2X3-13259-64970
4 vaccinations
4 coded responses
27 check-ins
4 free-text entries
3 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 982 / WA
- Registered
- 2021-02-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-20
Dose 1 — Moderna
-
2021-02-17
Registered in v-safe
-
2021-02-17
Dose 2 — Moderna
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-03-03
- 2021-03-11
- 2021-03-17
- 2021-03-26
- 2021-05-21
-
2021-08-18
Survey response — 6 months, dose 2MedDRA: Non-Hodgkin's lymphoma stage IV — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have been diagnosed with stage IV lymphoma.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-18
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-10
Dose 3 — Moderna
- 2021-12-09
-
2021-12-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-02-24
Survey response — 12 months, dose 2MedDRA: Pre-existing disease, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I have been diagnosed with 2 forms of cancer. Side effects of therapy are the cause of my feeling only fair.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-25
-
2022-03-02
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-04-20
Dose 4 — Moderna
-
2022-04-24
Survey response — days 1–6 daily, dose 4MedDRA: Malaise, Office visit, Pre-existing disease — Feeling: GoodFree text: I felt ill the day after the 4th shot. My oncologist thought it may have been a drug interaction with my cancer maintenance drugs, Opdivo and Calquence. The episode lasted 24 hours then subsided.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-25
- 2022-04-26
- 2022-04-27
- 2022-05-04
- 2022-05-13
- 2022-05-18
- 2022-05-25
- 2022-06-02
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: Condition aggravated, Office visit, Pre-existing disease, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Unrelated to Covid 19, my Lymphoma has recurred in 3 new locations. · Healthcare visit (other): Scheduled appointment with my oncologist followed by infusion immunotherapy.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-07-21
- 2022-10-19
- 2023-04-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-20 | Moderna | |
| 2 | 2021-02-17 | Moderna | |
| 3 | 2021-11-10 | Moderna | No |
| 4 | 2022-04-20 | Moderna | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 9 — 6 months, dose 2
Symptoms: I have been diagnosed with stage IV lymphoma.
Release 11 — 12 months, dose 2
Symptoms: I have been diagnosed with 2 forms of cancer. Side effects of therapy are the cause of my feeling only fair.
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): I felt ill the day after the 4th shot. My oncologist thought it may have been a drug interaction with my cancer maintenance drugs, Opdivo and Calquence. The episode lasted 24 hours then subsided.
Release 12 — 3 months, dose 4
Symptoms: Unrelated to Covid 19, my Lymphoma has recurred in 3 new locations.
Healthcare visit (other): Scheduled appointment with my oncologist followed by infusion immunotherapy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Non-Hodgkin's lymphoma stage IV | ✓ | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
| SRO | Malaise | · | · | ✓ |
| SRO | Office visit | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release